Logo image of OXBR

OXBRIDGE RE HOLDINGS LTD (OXBR) Stock Fundamental Analysis

NASDAQ:OXBR - Nasdaq - KYG6856M1069 - Common Stock - Currency: USD

2.04  +0.07 (+3.64%)

After market: 2.08 +0.04 (+1.96%)

Fundamental Rating

1

Overall OXBR gets a fundamental rating of 1 out of 10. We evaluated OXBR against 143 industry peers in the Insurance industry. Both the profitability and financial health of OXBR have multiple concerns. OXBR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

OXBR had negative earnings in the past year.
In the past year OXBR has reported a negative cash flow from operations.
OXBR had negative earnings in 4 of the past 5 years.
OXBR had a negative operating cash flow in each of the past 5 years.
OXBR Yearly Net Income VS EBIT VS OCF VS FCFOXBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M

1.2 Ratios

The Return On Assets of OXBR (-36.52%) is worse than 97.20% of its industry peers.
Looking at the Return On Equity, with a value of -69.05%, OXBR is doing worse than 93.71% of the companies in the same industry.
Industry RankSector Rank
ROA -36.52%
ROE -69.05%
ROIC N/A
ROA(3y)-55.81%
ROA(5y)-23.91%
ROE(3y)-88.98%
ROE(5y)-43.22%
ROIC(3y)N/A
ROIC(5y)N/A
OXBR Yearly ROA, ROE, ROICOXBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1.3 Margins

OXBR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OXBR Yearly Profit, Operating, Gross MarginsOXBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

More info and screens

1

2. Health

2.1 Basic Checks

OXBR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OXBR has more shares outstanding
The number of shares outstanding for OXBR has been increased compared to 5 years ago.
OXBR has a worse debt/assets ratio than last year.
OXBR Yearly Shares OutstandingOXBR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
OXBR Yearly Total Debt VS Total AssetsOXBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

A Debt/Equity ratio of 0.03 indicates that OXBR is not too dependend on debt financing.
OXBR has a Debt to Equity ratio of 0.03. This is amongst the best in the industry. OXBR outperforms 88.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC9.05%
OXBR Yearly LT Debt VS Equity VS FCFOXBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
OXBR Yearly Current Assets VS Current LiabilitesOXBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100K 200K 300K 400K 500K

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 73.41% over the past year.
OXBR shows a strong growth in Revenue. In the last year, the Revenue has grown by 42.82%.
Measured over the past years, OXBR shows a very strong growth in Revenue. The Revenue has been growing by 28.27% on average per year.
EPS 1Y (TTM)73.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.85%
Revenue 1Y (TTM)42.82%
Revenue growth 3Y-35.49%
Revenue growth 5Y28.27%
Sales Q2Q%136.75%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OXBR Yearly Revenue VS EstimatesOXBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

OXBR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OXBR Price Earnings VS Forward Price EarningsOXBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OXBR Per share dataOXBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

OXBR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OXBRIDGE RE HOLDINGS LTD

NASDAQ:OXBR (5/13/2025, 8:00:02 PM)

After market: 2.08 +0.04 (+1.96%)

2.04

+0.07 (+3.64%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)05-12 2025-05-12/amc
Earnings (Next)08-06 2025-08-06
Inst Owners8.01%
Inst Owner Change1.94%
Ins Owners9.24%
Ins Owner Change24.02%
Market Cap15.18M
Analysts0
Price TargetN/A
Short Float %0.17%
Short Ratio0.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.14
P/FCF N/A
P/OCF N/A
P/B 3.84
P/tB 3.84
EV/EBITDA N/A
EPS(TTM)-0.45
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.17
FCFYN/A
OCF(TTM)-0.17
OCFYN/A
SpS0.4
BVpS0.53
TBVpS0.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -36.52%
ROE -69.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-55.81%
ROA(5y)-23.91%
ROE(3y)-88.98%
ROE(5y)-43.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC9.05%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.09%
Cap/Sales(5y)0.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.85%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)42.82%
Revenue growth 3Y-35.49%
Revenue growth 5Y28.27%
Sales Q2Q%136.75%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y63.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y2.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2.22%
OCF growth 3YN/A
OCF growth 5YN/A